Overview

Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese(MEGA Study)

Status:
Completed
Trial end date:
2004-03-01
Target enrollment:
Participant gender:
Summary
To evaluate the primary preventive effect of low-dose pravastatin against coronary heart disease (CHD) in Japanese hypercholesterolemic patients.
Phase:
Phase 4
Details
Lead Sponsor:
Mitsukoshi Health and Welfare Foundation
Collaborators:
Daiichi Sankyo Co., Ltd.
Ministry of Health, Labour and Welfare, Japan
Treatments:
Pravastatin